Parkinson’s Disease Therapeutic Market – Analysis And Forecast (2017-2025): Market Shares And Strategies Of Key Players

Parkinsons-Disease-Therapeutic-Market

New product development is the key strategy adopted by major industry player in Parkinson’s disease therapeutic market

Key players in the Parkinson’s disease therapeutics market globally are Salix Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., Mylan N.V., Orion Corporation, Boehringer Ingelheim, UCB, and Impax Labs.  Many of the key players involved in the anti-Parkinson’s disease medication and some of the biopharmaceuticals research companies in the U.S. are currently in the development of new medicines for treatment of Parkinson’s disease. The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson’s disease treatment in the future.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/494

Increase in prevalence of Parkinson’s disease across the world is driving the Parkinson’s disease therapeutic market

According to Parkinson’s disease foundation, more than 10 million people globally are living with Parkinson’s disease and 60,000 Americans are diagnosed with Parkinson’s disease each year. The rising prevalence of Parkinson’s disease across the world is one of the major factor which is driving the Parkinson’s disease therapeutic market. Rising male patients, is also the major factor owing to Parkinson’s disease therapeutic market, because as mentioned in the data of Parkinson’s disease foundation, chances of getting Parkinson’s disease are one and half times more in men than women. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are some other causes which are likely to drive the Parkinson’s disease therapeutic market. However some restraints like expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the cessation of Parkinson’s disease therapeutic market.

Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and the risk increases with increasing age. Parkinson’s disease treatment is used to control symptoms such as uncontrolled movement, shakiness of hands, and some others. The therapeutic approaches like levodopa in combination with carbidopa is considered as an effective treatment over symptoms of Parkinson’s disease. The surgical treatment option is available but it is only effective for patients who are previously responded to levodopa therapy. The research and development in the field of Parkinson’s disease therapeutic will help in the treatment of Parkinson’s disease.

To get holistic SAMPLE of the report including table of contents: https://www.coherentmarketinsights.com/ongoing-insight/toc/494

New advancements in the treatment of parkinson’s disease has helped to boost the growth in North America for parkinson’s disease therapeutic market.

Regional segmentation of Parkinson’s disease therapeutic market according to coherent market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East, and Africa. High prevalence of Parkinson’s disease and good reimbursement policies are some of factors which allows the North America region to dominate in the Parkinson’s disease market. For instance, over 40 medicines are developed for the treatment of parkinsons disease and many have gained the fast track designation from U.S. Food and Drug Administration (FDA) in North America. North America is expected to hold the largest share in the Parkinson’s disease market because of increase in investments in research and development for Parkinson’s disease.

You may be interested

Carbon Fiber Reinforced Plastics Market Positive long-term growth outlook 2018-2026
Business
Business

Carbon Fiber Reinforced Plastics Market Positive long-term growth outlook 2018-2026

Sayali Tribhuvan - June 21, 2018

Carbon Fiber Reinforced Plastics Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market…

Smartphone Can Be Used As Car Key
Information Technology and Gadgets
Information Technology and Gadgets

Smartphone Can Be Used As Car Key

Sayali Tribhuvan - June 21, 2018

BMW exhibited their autonomous i3 electric car that can be summoned by phone at the Mobile World Congress (MWC), according to a report published on February 26,…

Scientists Discover 10,000 Black Holes at the Center of Galaxy
World News
World News

Scientists Discover 10,000 Black Holes at the Center of Galaxy

Sayali Tribhuvan - June 21, 2018

Scientists found 10,000 black holes at the center of Milky Way, according to a report published on April 4, 2018. The supermassive black hole at the center…

Most from this category